[EN] PHARMACEUTICAL COMPOSITION COMPRISING THE PLANT COLEONEMA<br/>[FR] COMPOSITION PHARMACEUTIQUE COMPORTANT LA PLANTE COLEONEMA
申请人:GROENEWALD JOHANNES GERHARDUS
公开号:WO2005105124A1
公开(公告)日:2005-11-10
The plant material or extract of the plant may be from C. album, C. nubigenum, C. juniperinum, C. calycinum, C. aspalathoides, C. pulchellum, C. virgatum and C. pulchrum. The pharmaceutical composition is particularly suitable for use as an immune stimulant, an antibacterial agent, an antifungal agent, an antiviral agent (in particular for treatment of HIV), an anti-inflammatory agent or an anti-oxidant. The composition may include at least one of the following compounds: 1, 2', 3'-dihydroxydihydrosuberosin (2H-1-benzopyran-2-one, 6-(2,3-dihydroxy-3-methylbutyl)-7-methoxy, 2H-1-benzopyran-2-one, 6-(3,3-dimethyloxiranyl)-7-methoxy); 5,5'-(tetrahydro-1H,3H-furo[3,4c]-furan-1,4-diyl)bis-[1S-(1 α.,3a.α,4.β.,6a)-1,3 benzodioxole; 6-(2,3-dihydroxy-3-methylbutyl)-7-methoxy-2H-1-benzopyran-2-one; 6-(3,3-dihydroxy-3-methylbutyl)-7-methoxy-2H1-benzopyran-2-one; 7-methoxy-6-(3,3-methyl-2butenyl)- 2H-1-benzopyran-2-one; 6-[(3,3-dimethyloxiranyl)methyl]-7-metoxy-2H-1-benzopyran-2-one; 6-(2 ,3-dihydroxy-3-methylbutyl)-7-methoxy-2H-1-benzopyran-2-one; 6-(3,3-dimethyloxiranyl) methyl]-7-metoxy-2H-1-benzopyran-2-one; Esculetin; 3,4-dihydro-5-hydroxy-2,2,8-trimethyl-2H,6H-benzo[1,2-b:5,4-b']dipyran-6-one; 2-(1-hydroxy-1-methylethyl)-2,3-dihydrofuro[3,2-g] chromen-7-one; 7-methoxy-6-(3-methyl-2-oxobutyl)- 2H-1-benzopyran-2-one; 2,2-dimethyl-pyrano(3,2-c)(1)benzopyran-5-one; 9,10-dihydro-9-hydroxy-8,8-dimethyl-2H,8H-Benzo[1,2-b:3,4-b']dipyran-2-one; n-hexadecanoic acid; 4-(4-hydroxyphenyl)- 2-butanone; 8-[ß-D-glucopyranosyloxy)-1-methylethyl]-8,9-dihydro-2H-furo[2,3-h]-1-benzopyran-2-one; 2-isopropenyl-2,3-dihydrofuro[3,2-g] chromen-7-one; 2-(3,4-dihydroxyphenyl)-3-(ß.-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one; Vitamin E; and pharmaceutically acceptable derivatives or salts thereof. A method of treating a patient using plant material or an extract as described above is also described, as is the compound 1, 2', 3'-dihydroxydihydrosuberosin and pharmaceutically acceptable derivatives or salts thereof for treating a patient.